So this topped the leaderboard for comments- which understandably brought it to my attention.
Now I'm an ex-holder, but have a lot of respect for the company and if you dig back through ancient history you'll find I was a big fan of 2591. So this post is not meant as a troll in any way.
Now I understand the argument that if a stock is notably undervalued, and the company has the cash, buy backs are good.
But I would have though that, given that NEU is looking to take 2591 to Ph III for several indications, that an extra $50m in the bank could be quite useful. I have to admit to having been slightly confounded by the decision when I saw it. I'd note that, given the market cap is way over $1b, pulling $50m worth of shares off the register isn't that much of a dent.
I realise the company has ~$200m cash in the bank- well done them- but my gut reaction would have been to hold back until they'd gotten 2591 licenced. My understanding is that the company is still somewhat inderdependent with Acadia so I would have held back until the company either had independent income or at least had diversified its co-dependencies.
If I'm missing something, happy to learn what that is.
- Forums
- ASX - By Stock
- NEU
- Why NEU shareholders should love the buyback !!!
NEU
neuren pharmaceuticals limited
Add to My Watchlist
11.2%
!
$13.94

Why NEU shareholders should love the buyback !!!, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.94 |
Change
1.400(11.2%) |
Mkt cap ! $1.728B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $5.554M | 410.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | $13.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.96 | 330 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 326 | 13.960 |
3 | 188 | 13.950 |
3 | 348 | 13.940 |
1 | 125 | 13.930 |
2 | 221 | 13.920 |
Price($) | Vol. | No. |
---|---|---|
13.980 | 81 | 1 |
13.990 | 1775 | 2 |
14.000 | 34812 | 15 |
14.010 | 486 | 3 |
14.020 | 790 | 4 |
Last trade - 10.57am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online